Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

Gimme Care vs NextMeds

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #45Desk pick
Gimme Care

Gimme Care offers compounded semaglutide ($130–$160/mo) and compounded tirzepatide ($163–$199/mo) including microdose options.

Marked down on: Five states require video/audio visits (KS, LA, MS, NM, WV)

vs
Dispatch #131
NextMeds

NextMeds is a cash-pay telehealth platform offering compounded semaglutide and compounded tirzepatide on a flat monthly membership — one price bundling the medication (if prescribed), telehealth visits, a…

Marked down on: Shows a LegitScript 'approval' but links only a generic directory search, not a verifiable seal — we couldn't independently confirm it

Gimme Care takes this head-to-head with the higher Desk Score, 81/100 (B−) against 71/100 (C) for NextMeds. NextMeds still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Gimme Care

81/100

B−

Overall

NextMeds

71/100

C

Price transparency

86
56

State access

86
86

Molecule range

66
66

Onboarding speed

86
78

Support responsiveness

72
82

Licensing & trust

88
62

The spec sheet

FieldGimme CareNextMeds
Semaglutide$130/mo (compounded)$129/mo (plus a separate fee, compounded)
Tirzepatide$163/mo (compounded)$179/mo (plus a separate fee, compounded)
CoverageAll 50 statesAll 50 states
Brand-nameCompounded onlyCompounded only
Oral optionInjectable onlyInjectable only
Best forReaders who want affordable compounded GLP-1 with nationwide coverage and microdose options.Readers who want flat-price compounded semaglutide or tirzepatide bundled with a care coach and registered dietitian.
Desk Score81/100B−71/100C

The verdict

Desk pick — Gimme Care

Gimme Care takes this head-to-head with the higher Desk Score, 81/100 (B−) against 71/100 (C) for NextMeds. NextMeds still holds its ground where its strengths line up with yours.

Choose Gimme Care if…

Readers who want affordable compounded GLP-1 with nationwide coverage and microdose options.

$130/mo (compounded) sema · $163/mo (compounded) tirz · All 50 states

Choose NextMeds if…

Readers who want flat-price compounded semaglutide or tirzepatide bundled with a care coach and registered dietitian.

$129/mo (plus a separate fee, compounded) sema · $179/mo (plus a separate fee, compounded) tirz · All 50 states

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Gimme Care · NextMeds.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.